CN1048242C - 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物 - Google Patents

5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物 Download PDF

Info

Publication number
CN1048242C
CN1048242C CN94108529A CN94108529A CN1048242C CN 1048242 C CN1048242 C CN 1048242C CN 94108529 A CN94108529 A CN 94108529A CN 94108529 A CN94108529 A CN 94108529A CN 1048242 C CN1048242 C CN 1048242C
Authority
CN
China
Prior art keywords
compound
methyl
amino
carboxylic acid
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94108529A
Other languages
English (en)
Chinese (zh)
Other versions
CN1117491A (zh
Inventor
伊藤安夫
加藤日出男
安田信吾
加户典幸
吉田敏彦
山本洋一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTHERN CONTINENTAL CO Ltd
Original Assignee
NORTHERN CONTINENTAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTHERN CONTINENTAL CO Ltd filed Critical NORTHERN CONTINENTAL CO Ltd
Publication of CN1117491A publication Critical patent/CN1117491A/zh
Application granted granted Critical
Publication of CN1048242C publication Critical patent/CN1048242C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epoxy Resins (AREA)
  • Medicinal Preparation (AREA)
CN94108529A 1993-08-27 1994-07-15 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物 Expired - Fee Related CN1048242C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP23431093 1993-08-27
JP234310/93 1993-08-27
JP286272/93 1993-10-22
JP28627293 1993-10-22
JP76318/94 1994-03-24
JP7631894 1994-03-24

Publications (2)

Publication Number Publication Date
CN1117491A CN1117491A (zh) 1996-02-28
CN1048242C true CN1048242C (zh) 2000-01-12

Family

ID=27302121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94108529A Expired - Fee Related CN1048242C (zh) 1993-08-27 1994-07-15 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物

Country Status (23)

Country Link
US (1) US5547962A (enExample)
EP (1) EP0641793B1 (enExample)
JP (1) JP2673937B2 (enExample)
KR (1) KR100218807B1 (enExample)
CN (1) CN1048242C (enExample)
AT (1) ATE144508T1 (enExample)
AU (1) AU676729B2 (enExample)
CA (1) CA2126118C (enExample)
CZ (1) CZ286524B6 (enExample)
DE (1) DE69400791T2 (enExample)
DK (1) DK0641793T3 (enExample)
ES (1) ES2096413T3 (enExample)
FI (1) FI113174B (enExample)
GR (1) GR3021715T3 (enExample)
HU (1) HU221952B1 (enExample)
IL (1) IL110060A (enExample)
MY (1) MY111702A (enExample)
NO (1) NO305515B1 (enExample)
NZ (1) NZ260851A (enExample)
PL (1) PL175870B1 (enExample)
SG (1) SG52147A1 (enExample)
TW (1) TW252107B (enExample)
UA (1) UA39859C2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022988A1 (en) * 1995-01-24 1996-08-01 Hokuriku Seiyaku Co., Ltd. Quinolinecarboxylic acid derivatives
US6121285A (en) 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
EP1015445B1 (en) * 1997-09-15 2009-02-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6531624B1 (en) 1998-11-18 2003-03-11 Asahi Glass Company Ltd. Aminoacrylic acid derivatives and process for producing the same
RU2270695C2 (ru) 1999-03-17 2006-02-27 Дайити Фармасьютикал Ко., Лтд. Фармацевтическая композиция
RU2299205C2 (ru) * 2000-02-09 2007-05-20 Дайити Фармасьютикал Ко., Лтд. Средство против кислотоустойчивых бактерий, содержащее пиридонкарбоновые кислоты в качестве активного компонента
US6825353B2 (en) 2000-02-25 2004-11-30 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acids and intermediates thereof
HK1048119A1 (en) * 2000-02-25 2003-03-21 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acids and intermediates thereof
KR20010044286A (ko) * 2001-02-01 2001-06-05 남근수 알킬-3-(2,6-디할로겐-5-플루오로)-옥소-3-피리딘프로피오네이트의 제조방법
EP1882685A4 (en) * 2005-05-20 2010-10-27 Daiichi Sankyo Co Ltd METHOD FOR PRODUCING AN ASYMMETRIC TETRASUBSTITUTED CARBON CONTAINING COMPOUND
WO2007037303A1 (ja) * 2005-09-28 2007-04-05 Daiichi Sankyo Company, Limited テトラ置換－５－アザスピロ[２．４]へプタン誘導体の製法およびその光学活性中間体
DK2001862T3 (da) * 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
JP4876165B2 (ja) * 2006-03-28 2012-02-15 ザ プロクター アンド ギャンブル カンパニー キノロン中間体を調製するための水素化物還元法
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
TWI362386B (en) * 2007-03-30 2012-04-21 Daiichi Sankyo Co Ltd A production method for the qunolon-carboxylic acid derivative
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63152318A (ja) * 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
JPH0219377A (ja) * 1988-07-08 1990-01-23 Kyorin Pharmaceut Co Ltd ８‐メチルキノロンカルボン酸誘導体

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62215572A (ja) 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
US5190955A (en) * 1987-01-28 1993-03-02 Bayer Aktiengesellschaft Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPS63275567A (ja) * 1987-05-07 1988-11-14 Dainippon Pharmaceut Co Ltd 新規キノリン誘導体、そのエステルおよびその塩
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
IL91648A (en) * 1988-09-22 1997-03-18 Abbott Lab Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
PT93420A (pt) * 1989-03-15 1990-11-07 Kanebo Ltd Processo para a preparacao de derivados de acido quinolinocarboxilico e de composicoes antibacterianas que os contem
EP0390215B1 (en) * 1989-03-30 1995-06-07 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation process es thereof, and antibacterial agents containing the same
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
NZ240883A (en) * 1990-12-05 1994-09-27 Synphar Lab Inc Antibacterial 7-substituted-6-fluoro-1,4-dihydro-4-oxo- quinoline-3-carboxylic acid derivatives
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63152318A (ja) * 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
JPH0219377A (ja) * 1988-07-08 1990-01-23 Kyorin Pharmaceut Co Ltd ８‐メチルキノロンカルボン酸誘導体

Also Published As

Publication number Publication date
TW252107B (enExample) 1995-07-21
UA39859C2 (uk) 2001-07-16
FI113174B (fi) 2004-03-15
EP0641793B1 (en) 1996-10-23
US5547962A (en) 1996-08-20
IL110060A0 (en) 1994-10-07
NO942309L (no) 1995-02-28
NZ260851A (en) 1996-03-26
NO305515B1 (no) 1999-06-14
CZ157494A3 (en) 1995-10-18
CZ286524B6 (cs) 2000-05-17
PL304063A1 (en) 1995-03-06
DE69400791D1 (de) 1996-11-28
GR3021715T3 (en) 1997-02-28
DE69400791T2 (de) 1997-03-06
IL110060A (en) 1999-10-28
CA2126118C (en) 2001-02-06
JPH07309864A (ja) 1995-11-28
JP2673937B2 (ja) 1997-11-05
MY111702A (en) 2000-11-30
DK0641793T3 (da) 1996-11-25
ATE144508T1 (de) 1996-11-15
CA2126118A1 (en) 1995-02-28
KR100218807B1 (ko) 1999-09-01
KR950005823A (ko) 1995-03-20
HU221952B1 (hu) 2003-03-28
HU9401954D0 (en) 1994-09-28
FI942976A7 (fi) 1995-02-28
ES2096413T3 (es) 1997-03-01
HUT67259A (en) 1995-03-28
EP0641793A1 (en) 1995-03-08
SG52147A1 (en) 1998-09-28
AU6487094A (en) 1995-03-09
CN1117491A (zh) 1996-02-28
FI942976A0 (fi) 1994-06-21
PL175870B1 (pl) 1999-02-26
NO942309D0 (no) 1994-06-17
AU676729B2 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1130345C (zh) 氨基喹啉衍生物
CN1446218A (zh) 苯并咪唑衍生物,它们的制备方法以及它们的治疗应用
CN1009930B (zh) 含喹啉羧酸衍生物的药物组合物的制备方法
CN1674898A (zh) 作为促旋酶和 /或拓扑异构酶 i v的抑制剂用于治疗细菌感染的 2 －脲基－6－杂芳基－3 h－苯并咪唑－4－羧酸衍生物和相关化合物
CN1114959A (zh) 有7-(4-氨基甲基-3-肟)吡咯烷取代基的新喹啉羧酸衍生物和其制法
CN1630639A (zh) 新型吡啶－和喹啉－衍生物
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1933834A (zh) 吲唑甲酰胺衍生物在制备用于治疗和预防疟疾的药物中的用途
CN1788002A (zh) 作为钠通道阻滞剂的联芳基取代的三唑化合物
CN1795195A (zh) 新颖的吡啶并吡嗪及其作为激酶调节剂的用途
CN1267432C (zh) 2－吡啶基－6,7,8,9－四氢嘧啶并[1,2－a]嘧啶－4－酮和7－吡啶基－2,3－二氢咪唑并[1,2－a]嘧啶－5(1H)酮衍生物
CN1511151A (zh) 3-喹啉-2(1h)-亚基二氢吲哚-2-酮衍生物
CN1032438A (zh) 新的取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺
CN1784408A (zh) 8－取代的－6,7,8,9－四氢嘧啶并[1,2－a]嘧啶－4－酮衍生物
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
CN1130346C (zh) 作为nmda拮抗剂的四氢喹啉类化合物
CN1251836A (zh) 单环β－内酰胺类抗生素衍生物的中间体的制备方法
CN1244577C (zh) 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物
CN1422256A (zh) 包含作为活性成分的吡啶酮羧酸的抗耐酸细菌药
CN1665503A (zh) 杂芳烃甲酰胺作为多巴胺－d3配体用于治疗中枢神经系统疾病的用途
CN1750824A (zh) 用于治疗局部缺血性损伤的4－[(2,4－二氯－5－甲氧苯基)氨基]－6－烷氧基－3－氰基喹琳类
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1756753A (zh) 苯并呋喃衍生物
CN1102527A (zh) 末梢血管舒张剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20000112

Termination date: 20090817